CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Primary analysis of the prospective, randomized, phase II trial of GP2+GM-CSF vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.
Authors
Alexandros Ardavanis
Alfred F. Trappey
+14Â more
Diane F. Hale
Elizabeth Ann Mittendorf
Erika J Schneble
George Earl Peoples
Guy T. Clifton
James L. Murray
Jennifer Keating Litton
John S. Berry
Julia M. Greene
Michael Papamichail
Nathan M. Shumway
Sathibalan Ponniah
Sonia A. Perez
Timothy J. Vreeland
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1200%2Fjco.2014.32...
Last time updated on 25/10/2020